Sputnik V - Third vaccine against COVID19 in India

"The first dose of Sputnik V vaccine was administered in Hyderabad”

Sputnik V is the third COVID19 vaccine available in India after Covaxin and Covishield. It is made by Gamaleya Research Institute of Epidemiology and Microbiology, Moscow. It is a two-dose vaccine same as Covishield and Covaxin. This vaccine has an efficacy of 91% as per the researchers. Dr. Reddy’s Laboratories has received 1,50,000 doses of this vaccine from Russia. However, the company expects more doses of it in near future. The first dose of Sputnik V was administered in Hyderabad. 

This vaccine is costing Rs. 995 per dose, this includes 5% of GST. Covishield which is being manufactured by Serum Institute of India, Pune is costing Rs. 300 per dose to States and Rs. 600 per dose to private hospitals. Covaxin is priced at Rs. 400 per dose to States and Rs. 1200 per dose to private hospitals. However, Dr. Reddy’s Laboratories has set the same price for Government and private channels. 

20% initial supply of Sputnik V will be imported from Russia. “There is a commitment of 36 million doses from RDIF (Russian Direct Investment Fund) in next 2 months”, said Vice President, Dr. Reddy’s. The laboratory will soon bring single dose Sputnik Light vaccine in India.

Tags : #Spotlight #SputnikV #DRL #Covishield #PriceofSputnik #FirstdoseofSputnik #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024